These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8518038)

  • 1. High-dose folinic acid, 5-fluorouracil bolus and infusion in advanced pancreatic adenocarcinoma: a pilot study.
    Louvet C; Beerblock K; de Gramont A; Varette C; Demuynck B; Bennamoun M; Cady J; Delfau S; Maisani JE; Krulik M
    Eur J Cancer; 1993; 29A(8):1217. PubMed ID: 8518038
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose folinic acid with 5-fluorouracil bolus and continuous infusion in the treatment of advanced gastric and oesophageal adenocarcinoma.
    Highley MS; Hill ME; Ziras N; Samandas N; Mason RC; Owen W; Dussek J; Barker S; Harper PG
    Br J Cancer; 1993 Feb; 67(2):407-8. PubMed ID: 8431376
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of advanced pancreatic cancer with 5-fluorouracil, folinic acid and interferon alpha-2A: results of a phase II trial.
    Bernhard H; Jäger-Arand E; Bernhard G; Heike M; Klein O; Riemann JF; Meyer zum Büschenfelde KH; Dippold W; Knuth A
    Br J Cancer; 1995 Jan; 71(1):102-5. PubMed ID: 7819023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study.
    Whitehead RP; Benedetti JK; Abbruzzese JL; Ardalan B; Goodwin JW; Balcerzak SP; Samlowski WE; Lenz HJ; Macdonald JS
    Invest New Drugs; 2004 Aug; 22(3):335-41. PubMed ID: 15122082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
    Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
    Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of 5-fluorouracil, leucovorin and cisplatin in advanced pancreatic cancer.
    Huguier M; Barrier A; Valinas R; Flahault A; Adloff M; Pezet D; Jaeck D; Millat B;
    Hepatogastroenterology; 2001; 48(39):875-8. PubMed ID: 11462946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [5-FU, folinic acid and cisplatin (LV5FU2-P) for unresectable pancreatic cancer].
    Taïeb J; Lecomte T; Ezenfis J; Artru P; Mitry E; Boige V; Clavero-Fabri MC; Vaillant JN; Rougier P; Ducreux M
    Gastroenterol Clin Biol; 2002; 26(6-7):605-9. PubMed ID: 12193860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin.
    Kornek GV; Schratter-Sehn A; Marczell A; Depisch D; Karner J; Krauss G; Haider K; Kwasny W; Locker G; Scheithauer W
    Br J Cancer; 2000 Jan; 82(1):98-103. PubMed ID: 10638974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in chemotherapy for pancreatic adenocarcinoma].
    Hammel P
    Gastroenterol Clin Biol; 2002; 26(6-7):603-4. PubMed ID: 12193859
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical benefit with cisplatin, hydroxyurea and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma.
    Raymond E; de Gramont A; Louvet C; Tournigand C; Demuynck B; Beerblock K; Carola E; Krulik M
    Eur J Cancer; 1997 Apr; 33(4):696-7. PubMed ID: 9274458
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of cyclophosphamide, leucovorin, 5-fluorouracil 24-hour infusion and tamoxifen in pancreatic cancer.
    Eckel F; Lersch C; Lippl F; Assmann G; Schulte-Frohlinde E
    J Exp Clin Cancer Res; 2000 Sep; 19(3):295-300. PubMed ID: 11144522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial.
    DeCaprio JA; Mayer RJ; Gonin R; Arbuck SG
    J Clin Oncol; 1991 Dec; 9(12):2128-33. PubMed ID: 1960554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma.
    Crown J; Casper ES; Botet J; Murray P; Kelsen DP
    J Clin Oncol; 1991 Sep; 9(9):1682-6. PubMed ID: 1875224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700.
    Isacoff WH; Bendetti JK; Barstis JJ; Jazieh AR; Macdonald JS; Philip PA
    J Clin Oncol; 2007 May; 25(13):1665-9. PubMed ID: 17470859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorouracil, high-dose folinic acid, and mitomycin C combination chemotherapy in advanced gastrointestinal adenocarcinomas. A pilot study.
    Becouarn Y; Brunet R; Bussières E; Marée D
    Oncology; 1988; 45(4):269-72. PubMed ID: 3133620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of advanced colonic and rectal adenocarcinoma: combination of 5-FU and high-dose folinic acid].
    Rougier P; Droz JP; Ducreux M; Kac J; Spielmann M; Crespon B; Ley G; Zimmermann P; Theodore C; Chavy A
    Bull Cancer; 1983; 70(5):434-6. PubMed ID: 6607759
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
    Machover D; Goldschmidt E; Chollet P; Metzger G; Zittoun J; Marquet J; Vandenbulcke JM; Misset JL; Schwarzenberg L; Fourtillan JB
    J Clin Oncol; 1986 May; 4(5):685-96. PubMed ID: 3517242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I/II study of leucovorin, carboplatin and 5-fluorouracil (LCF) in patients with carcinoma of unknown primary site or advanced oesophagogastric/pancreatic adenocarcinomas.
    Rigg A; Cunningham D; Gore M; Hill M; O'Brien M; Nicolson M; Chang J; Watson M; Norman A; Hill A; Oates J; Moore H; Ross P
    Br J Cancer; 1997; 75(1):101-5. PubMed ID: 9000605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a 48-hour infusion of 5-fluorouracil without folinic acid with 24-hour folinic acid/5-fluorouracil in patients with metastatic colorectal cancer refractory to bolus folinic acid/5-fluorouracil. A prospective cohort study.
    Moehler M; Gutzler F; Steinmann S; Boehme M; Raeth U; Stremmel W; Galle PR; Rudi J
    Chemotherapy; 2003 May; 49(1-2):85-9. PubMed ID: 12714817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Fluorouracil combined with the [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma. A phase I-II study of two consecutive regimens.
    Machover D; Grison X; Goldschmidt E; Zittoun J; Metzger G; Richaud J; Lotz JP; André T; Hannoun L; Marquet J
    Ann Oncol; 1993; 4 Suppl 2():29-35. PubMed ID: 8353102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.